Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,109,163
- Total 13F shares
- 172,656,651
- Share change
- +3,776,784
- Total reported value
- $121,134,385
- Put/Call ratio
- 1.7%
- Price per share
- $0.70
- Number of holders
- 187
- Value change
- -$6,847,947
- Number of buys
- 73
- Number of sells
- 105
Report period
Q1 2023
Institutions
187
Top holders
10
NKTR full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Invesco Ltd. |
13F
|
Company |
128%
|
37,327,473
|
$84,360,090 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
123%
|
35,930,715
|
$81,203,415 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
79%
|
23,065,775
|
$52,128,652 | — | 31 Dec 2022 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
54%
|
15,659,053
|
$35,389,460 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
25%
|
7,335,587
|
$16,578,427 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
12%
|
3,443,711
|
$7,782,000 | — | 31 Dec 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
8.8%
|
2,570,849
|
$5,810,119 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
8.8%
|
2,550,049
|
$5,762,000 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
6.5%
|
1,882,378
|
$4,254,174 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
6.4%
|
1,867,514
|
$4,220,583 | — | 31 Dec 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
6.4%
|
1,852,900
|
$4,187,554 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
5.8%
|
1,696,851
|
$3,834,883 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
5.6%
|
1,643,239
|
$3,713,722 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
5.6%
|
1,631,395
|
$3,686,953 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
4.7%
|
1,376,192
|
$3,110,194 | — | 31 Dec 2022 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
4.6%
|
1,334,661
|
$3,016,334 | — | 31 Dec 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
4%
|
1,177,797
|
$2,661,821 | — | 31 Dec 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
4%
|
1,155,873
|
$2,612,000 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.9%
|
1,127,916
|
$2,549,090 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
3.7%
|
1,083,992
|
$2,449,821 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.1%
|
892,949
|
$2,017,000 | — | 31 Dec 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
2.2%
|
645,035
|
$1,458,000 | — | 31 Dec 2022 | |
| BRAIDWELL LP |
13F
|
Company |
2.1%
|
620,280
|
$1,401,833 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
612,909
|
$1,385,000 | — | 31 Dec 2022 | |
| Edgestream Partners, L.P. |
13F
|
Company |
2.1%
|
608,851
|
$1,376,003 | — | 31 Dec 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
2%
|
595,938
|
$1,346,757 | — | 31 Dec 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
2%
|
576,888
|
$1,304,000 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.9%
|
561,727
|
$1,270,000 | — | 31 Dec 2022 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
1.9%
|
550,000
|
$1,243,000 | — | 31 Dec 2022 | |
| Legal & General Group Plc |
13F
|
Company |
1.9%
|
541,429
|
$1,223,629 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.8%
|
533,642
|
$1,206,031 | — | 31 Dec 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
1.7%
|
492,500
|
$1,113,000 | — | 31 Dec 2022 | |
| Walleye Capital LLC |
13F
|
Company |
1.7%
|
482,907
|
$1,091,370 | — | 31 Dec 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.6%
|
474,258
|
$1,071,823 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
1.6%
|
452,500
|
$1,022,650 | — | 31 Dec 2022 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
442,858
|
$961,002 | — | 31 Dec 2022 | |
| Graham Capital Management, L.P. |
13F
|
Company |
1.5%
|
431,897
|
$976,087 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
1.5%
|
427,598
|
$966,370 | — | 31 Dec 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
1.4%
|
420,455
|
$950,000 | — | 31 Dec 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.4%
|
397,744
|
$898,901 | — | 31 Dec 2022 | |
| AXA S.A. |
13F
|
Company |
1.3%
|
387,500
|
$875,750 | — | 31 Dec 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
1.3%
|
366,202
|
$827,617 | — | 31 Dec 2022 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
1.2%
|
347,612
|
$786,000 | — | 31 Dec 2022 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
1.2%
|
344,460
|
$778,480 | — | 31 Dec 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1%
|
299,268
|
$676,000 | — | 31 Dec 2022 | |
| York State Teachers Retirement System New |
13F
|
Individual |
0.91%
|
266,340
|
$602,000 | — | 31 Dec 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.91%
|
265,827
|
$601,000 | — | 31 Dec 2022 | |
| CAXTON ASSOCIATES LP |
13F
|
Company |
0.89%
|
259,677
|
$586,870 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.89%
|
257,874
|
$583,000 | — | 31 Dec 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.88%
|
256,385
|
$579,000 | — | 31 Dec 2022 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q1 2023
As of 31 Mar 2023,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
172,656,651 shares.
The largest 10 holders included
Invesco Ltd., BlackRock Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, STATE STREET CORP, PICTET ASSET MANAGEMENT SA, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., RENAISSANCE TECHNOLOGIES LLC, and CITADEL ADVISORS LLC.
This page lists
187
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
209
Q1 2023 holders
187
Holder diff
-22
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.